Last updated: July 17, 2026

Application No. 18/569,346

PHARMACEUTICAL FORMULATION CONTAINING AN ANTI-IgE ANTIBODY

Non-Final OA

Filed

Dec 12, 2023

Priority

Jun 14, 2021 — IN PCT/IB2021/055217 +1 more

Examiner

LIU, SUE XU

Art Unit

1646

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Novartis AG

OA Round

1 (Non-Final)

This examiner grants 20% of cases after interview

— +16.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 234 resolved cases, 2023–2026

Examiner Intelligence

LIU, SUE XU View full profile →

Grants only 20% of cases

Career Allowance Rate

47 granted / 234 resolved

-39.9% vs TC avg

Strong +16% interview lift

Without

With

+16.5%

Interview Lift

resolved cases with interview

Typical timeline

4y 5m

Avg Prosecution

19 currently pending

Career history

261

Total Applications

across all art units

Statute-Specific Performance

§101

1.8%

-38.2% vs TC avg

§103

63.6%

+23.6% vs TC avg

§102

4.3%

-35.7% vs TC avg

§112

9.3%

-30.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 234 resolved cases

Prosecution Timeline

Dec 12, 2023

Application Filed

May 19, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/606,262

Patent 12616677

INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

4y 6m to grant Granted May 05, 2026

18/245,971

Patent 12616206

GRAPHENE-SILVER NANOCOMPOSITES AND USES FOR SAME AS AN ANTIMICROBIAL COMPOSITION

3y 1m to grant Granted May 05, 2026

18/638,945

Patent 12616198

LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH

2y 0m to grant Granted May 05, 2026

17/462,664

Patent 12610946

FORMULATIONS FOR DECONTAMINATING A SURFACE

4y 8m to grant Granted Apr 28, 2026

17/690,520

Patent 12611374

DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS

4y 1m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

20%

Grant Probability

37%

With Interview (+16.5%)

4y 5m (~1y 10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 234 resolved cases by this examiner. Grant probability derived from career allowance rate.